Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Farmers Insurance
Accenture
Julphar
Moodys
Healthtrust
Fuji
Novartis
Chinese Patent Office
US Department of Justice

Generated: October 21, 2017

DrugPatentWatch Database Preview

Ipratropium bromide - Generic Drug Details

« Back to Dashboard

What are the generic sources for ipratropium bromide and what is the scope of ipratropium bromide freedom to operate?

Ipratropium bromide
is the generic ingredient in three branded drugs marketed by Sun Pharma Global, Bausch And Lomb, Pharmascience Inc, Actavis Mid Atlantic, Teva Pharms Usa, Boehringer Ingelheim, Bausch And Lomb Inc, Apotex Inc, Aurobindo Pharma Ltd, Mylan Speciality Lp, Nephron, West-ward Pharms Int, Roxane, Landela Pharm, Watson Labs, and Ritedose Corp, and is included in twenty-six NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ipratropium bromide has fifty-eight patent family members in thirty-seven countries.

There are seven drug master file entries for ipratropium bromide. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: ipratropium bromide

US Patents:3
Tradenames:3
Applicants:16
NDAs:26
Drug Master File Entries: see list7
Suppliers / Packagers: see list21
Bulk Api Vendors: see list60
Clinical Trials: see list316
Patent Applications: see list7,762
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ipratropium bromide at DailyMed

Pharmacology for Ingredient: ipratropium bromide

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmascience Inc
IPRATROPIUM BROMIDE
ipratropium bromide
SOLUTION;INHALATION075507-001Jan 19, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Bausch And Lomb
IPRATROPIUM BROMIDE
ipratropium bromide
SPRAY, METERED;NASAL076103-001Mar 31, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Ritedose Corp
IPRATROPIUM BROMIDE
ipratropium bromide
SOLUTION;INHALATION075693-001Jan 26, 2001ANRXNoYes► Subscribe► Subscribe► Subscribe
Apotex Inc
IPRATROPIUM BROMIDE
ipratropium bromide
SPRAY, METERED;NASAL076155-001Apr 18, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Bausch And Lomb
IPRATROPIUM BROMIDE
ipratropium bromide
SPRAY, METERED;NASAL076025-001Mar 31, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Nephron
IPRATROPIUM BROMIDE
ipratropium bromide
SOLUTION;INHALATION075562-001Sep 27, 2001ANRXNoNo► Subscribe► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020394-001Oct 20, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
Watson Labs
IPRATROPIUM BROMIDE
ipratropium bromide
SOLUTION;INHALATION076291-001May 9, 2005ANRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Speciality Lp
IPRATROPIUM BROMIDE
ipratropium bromide
SPRAY, METERED;NASAL075553-001Mar 31, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 2004RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ipratropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020394-001Oct 20, 1995► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
AEROSOL, METERED;INHALATION019085-001Dec 29, 1986► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 2004► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020393-001Oct 20, 1995► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 2004► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 2004► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ipratropium bromide

Country Document Number Estimated Expiration
Australia5809200► Subscribe
Portugal1198395► Subscribe
Canada2700201► Subscribe
Austria289276► Subscribe
Eurasian Patent Organization003690► Subscribe
Denmark2203205► Subscribe
Malaysia128067► Subscribe
Bulgaria64861► Subscribe
Estonia04394► Subscribe
Hong Kong1045973► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Cipla
Merck
Dow
Boehringer Ingelheim
Argus Health
US Army
Medtronic
Baxter
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot